asco 2018 - dream study - chemo with imfinzi (durvalumab) for mesothelioma
Published 5 years ago • 244 plays • Length 4:26Download video MP4
Download video MP3
Similar videos
-
9:40
asco 2018 - checkmate 227 - combinations of nivolumab and ipilimumab, or nivolumab and and chemo
-
11:29
asco 2018 keynote189 - cisplatin or carboplatin with alimta & keytruda - practice changing approach?
-
11:58
asco lung cancer roundtable - mesothelioma updates
-
7:28
egfrm nsclc: should we treat with durvalumab? - asco lung review 2022
-
12:26
asco 2018 - potential showdown of two positive trials? keynote 407 and impower 131
-
2:13
lung cancer video library - immunotherapy in stage lll nsclc - the pacific trial and imfinzi
-
7:35
asco 2018 - will taking mod to high dose steroids affect lung cancer pts on immunotherapy?
-
9:11
asco 2018 - tarceva or tarceva with avastin as 1st line for egfr pos. nsclc vs. tagrisso or vizimpro
-
6:27
asco 2018 - tarceva combined with carboplatin & alimta - given upfront - affect pace of disease?
-
2:52
asco 2018 - combining metformin with standard egfr therapy - is the jury still out
-
13:45
curative modalities & immunotherapy for head & neck cancer - 2021 asco esmo head & neck recap
-
19:28
asco/esmo 2020 - keynote 048 study update, what have we learned?
-
0:54
askunmc: smell distortion
-
4:13
#askaboutasthma 2022 - mitigating air pollution exposure to manage asthma
-
23:32
gracecast-077_lung-cancer_asco 2011 highlights - advanced/metastatic nsclc